ClosedHealth & Human Services
Building Sustainable Health Systems and Laboratory Services in Cote d'Ivoire under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGHCDC-RFA-GH21-2151
Description
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,000,000 for Year 1, subject to the availability of funds.The NOFO will support Ivorian laboratory institutions and provide necessary interventions to achieve HIV epidemic control. This NOFO will complement PEPFAR clinical and community program interventions by increasing and sustaining access to quality laboratory services for all HIV patients on antiretroviral treatment (ART) in order to improve clinical outcomes and reduce new infections and HIV-associated morbidity and mortality in Côte d’Ivoire. Activities will consist of direct site support or technical assistance (TA), focusing on 5 strategies:•Coordinate the national specimen transportation system•Strengthen the national laboratory workforce, laboratory professional network, and lab-clinical interface•Integrate the laboratory management information system (LMIS) with the national health management information system (HMIS) to provide high quality laboratory and patient information across systems•Strengthen national laboratory policies and institutions and improve adherence to national guidelines•Implement Quality Management Systems (QMS) in all laboratory networks to increase the number of labs, points of care (POC), and voluntary counseling and testing sites (VCT) providing quality servicesThe recipient will provide support and TA to the national public health laboratory (NPHL), HIV/AIDS program (PNLS), HMIS directorate (DIIS), district health teams, and PEPFAR implementing partners (IPs). The scope of the NOFO is nationwide with a focus on 60 PEPFAR-supported health districts.
CFDA Number
93.067
Funding Instrument
Cooperative Agreement
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
January 8, 2021
Close Date
April 2, 2021
Posted Date
January 8, 2021
Eligible Applicant Types
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Tags
HHS-CDC-CGHCFDA:93.067Cooperative AgreementHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left